Trials / Completed
CompletedNCT03501173
A Study of Participants With Advanced Prostate Cancer in Canada
A Multicentre Cohort Study of Patients With Advanced Prostate Cancer in Canada
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 374 (actual)
- Sponsor
- Janssen Inc. · Industry
- Sex
- Male
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to document the course of advanced prostate cancer in Canada in terms of disease progression, real-world treatment, and patient management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Standard of Care | Participants will not receive any intervention in this study. Participants will receive standard of care therapy. |
Timeline
- Start date
- 2018-04-12
- Primary completion
- 2023-07-14
- Completion
- 2023-07-14
- First posted
- 2018-04-18
- Last updated
- 2023-07-25
Locations
22 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT03501173. Inclusion in this directory is not an endorsement.